Description: Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provides toothpaste, and mouth wash and gel products under the Oral7 name; and food and medical beauty maintenance products. Further, it imports and exports active pharmaceutical ingredients; and engages in the research of technologies, and pharmaceutical technologies transfer and cooperative development and improvement activities. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was incorporated in 1988 and is headquartered in Taipei, Taiwan.
Home Page: www.excelsiorgroup.com.tw
No.3, Park Street
Taipei,
11503
Taiwan
Phone:
886 2 2655 7568
Officers
Name | Title |
---|---|
Mr. Joseph Chen | Founder, Chairman, Pres & GM |
Mr. MingTse Chen | Financial Mang. & Chief Accountant |
Ms. HuiChen Liu | Representative Director & Admin. Department Mang. |
Mr. Po-Tang Cheng | Sr. Sales Director |
Ms. Chialing Chen | Representative Director, New Bus. Devel. Mang. & Associate Manger to the Pres Office |
Exchange: TWO
Country: TW
Currency: New Taiwan Dollar (NT$)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.0937 |
Price-to-Sales TTM: | 1.5053 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 0 |